27.00
+0.50
+(1.89%)
At close: April 17 at 4:00:01 PM EDT
27.77
+0.77
+(2.85%)
After hours: April 17 at 7:58:03 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
125,595
125,595
93,105
55,550
Cost of Revenue
203,617
203,617
188,716
171,997
Gross Profit
-78,022
-78,022
-95,611
-116,447
Operating Expense
690,200
690,200
701,305
626,012
Operating Income
-768,222
-768,222
-796,916
-742,459
Net Non Operating Interest Income Expense
26,733
26,733
7,954
1,740
Other Income Expense
-1,420,872
-1,420,872
-718,674
-4,700,669
Pretax Income
-2,162,361
-2,162,361
-1,507,636
-5,441,388
Tax Provision
-135,356
-135,356
-41,951
-42,290
Net Income Common Stockholders
-2,027,005
-2,027,005
-1,465,685
-5,399,098
Diluted NI Available to Com Stockholders
-2,027,005
-2,027,005
-1,465,685
-5,399,098
Basic EPS
-63.54
-63.54
-47.20
-173.87
Diluted EPS
-63.54
-63.54
-47.20
-173.87
Basic Average Shares
31,901.26
31,901.26
31,052.63
31,052.63
Diluted Average Shares
31,901.26
31,901.26
31,052.63
31,052.63
Total Operating Income as Reported
-2,189,158
-2,189,158
-1,515,382
-5,442,890
Total Expenses
893,817
893,817
890,021
798,009
Net Income from Continuing & Discontinued Operation
-2,027,005
-2,027,005
-1,465,685
-5,399,098
Normalized Income
-695,014.47
-695,014.47
-767,210.81
-735,198.35
Interest Income
26,733
26,733
7,954
1,740
Net Interest Income
26,733
26,733
7,954
1,740
EBIT
-768,222
-768,222
-796,916
-742,459
EBITDA
-610,166
-610,166
-638,219
-587,696
Reconciled Cost of Revenue
203,617
203,617
188,716
171,997
Reconciled Depreciation
158,056
158,056
158,697
154,763
Net Income from Continuing Operation Net Minority Interest
-2,027,005
-2,027,005
-1,465,685
-5,399,098
Total Unusual Items Excluding Goodwill
-1,420,936
-1,420,936
-718,466
-4,700,431
Total Unusual Items
-1,420,936
-1,420,936
-718,466
-4,700,431
Normalized EBITDA
810,770
810,770
80,247
4,112,735
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
-88,945.47
-88,945.47
-19,991.81
-36,531.35
12/31/2022 - 6/12/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ILMN Illumina, Inc.
71.20
-3.17%
GH Guardant Health, Inc.
44.97
-0.46%
WGS GeneDx Holdings Corp.
95.47
-2.86%
NTRA Natera, Inc.
148.08
-1.39%
EXAS Exact Sciences Corporation
41.58
-1.61%
TWST Twist Bioscience Corporation
36.80
-4.29%
MYGN Myriad Genetics, Inc.
7.64
-3.41%
LH Labcorp Holdings Inc.
217.12
-1.56%
DGX Quest Diagnostics Incorporated
163.80
-0.41%
TMO Thermo Fisher Scientific Inc.
427.50
-2.13%